Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: A pilot study

Retina

Volumn 29, Issue 4, 2009, Pages 530-535

  Lanzagorta Aresti, Aitor ^a,b   Palacios Pozo, Elena ^a   Menezo Rozalen, Jose Luis ^a   Navea Tejerina, Amparo ^a  

^a Fundacion Oftalmologica del Mediterraneo   (Spain)

^b NONE   (Spain)

Author keywords

Bevacizumab; Cataract; Diabetic macular edema; Phacoemulsification.

Indexed keywords

BALANCED SALT SOLUTION; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; PILOT STUDY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; SPAIN; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; CATARACT EXTRACTION; DISEASE COURSE; DRUG ANTAGONISM; INJECTION; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RETINA MACULA EDEMA; VISUAL DISORDER; VITREOUS BODY;

ANTIBODIES, MONOCLONAL; CATARACT EXTRACTION; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; INJECTIONS; MACULAR EDEMA; PILOT PROJECTS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION DISORDERS; VISUAL ACUITY; VITREOUS BODY;

EID: 66149107109     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31819c6302     Document Type: Article

References (25)

1. Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol 1992;76:221-224.
2. Malecaze F. Cataract surgery in diabetics. J Fr Ophtalmol 2003;26:525-527.
3. Poliner LS, Christianson DJ, Escoffrey RF, Kolker AE, Gordon ME. Neovascular glaucoma after intracapsular and extra-capsular cataract extraction in diabetic patients. Am J Ophthalmol 1985;100:637-643.
4. Chung J, Kim MY, Kim HS, Yoo JS, Lee YC. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg 2002;25:626-630.
5. Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1992;114:448-456.
6. Mittra RA, Borillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol 2000;118:912-917.
7. Murtha T, Cavallerano J. The management of diabetic eye disease in the setting of cataract surgery. Curr Opin Ophthalmol 2007;18:13-18.
8. Funatsu H, Yamashita H, Noma H, Shimisu E, Mimura T, Hori S. Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy. J Cataract Refract Surg 2002;28:1355.
9. Habib MS, Cannon PS, Steel DHW. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabetic foveal edema and cataract. BMC Ophthalmol 2005;5:15.
10. Bobbili DO, Mathai A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2006;142:695-702.
11. Macugen Diabetic Retinopathy Study Group. A Phase II randomized double-masked trial pegaptanib, an antivascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112:1747-1757.
12. Chun DW, Heier JS, Topping TM, Duker JS, Bankert JM. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 2006;113:1706-1712.
13. Patel JI, Hykin PG, Cree IA. Diabetic cataract removal: postoperative of maculopathy-growth factor and clinical análisis. Br J Ophthalmol 2006;90:697-701.
14. Aiello LP, Avery RL, Arriga PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331: 1480-1487.
15. Qaum T, Xu Q, Joussen A, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2001;42:2408 -2413.
16. Canton A, Burgos R, Hernandez C, et al. Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy. Br J Ophthalmol 2000;84:732-735.
17. Luna JD, Chan CC, Derevjanik NL, et al. Blood-retinal barrier breakdown in experimental autoimmune uveorretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha and interleukin 1 beta mediated breakdown. J Neurosci Res 1997;49:268-280.
18. Rosenfeld P, Fung A, Puliafito C. Optical coherence tomography findings after intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-339.
19. Haritoglou C, Kook D, Neubauer A, Wolf A, et al. Intravitreal bevacizumab (avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
20. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, et al. Primary intravitreal bevacizumab (avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month-follow-up. Ophthalmology 2007;114: 743-750.
21. Larsson J, Zhu M, Sutter F, Gillies MC. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 2005;139:802-806.
22. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2002;240:735-738.
23. Romeo-Aroca P, Fernández-Ballart J, Almena-García M, Méndez-Martín I, Salvat-Serra M, Buil-Calvo JA. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. J Cataract Refract Surg 2006;32:1438-1444.
24. Dowler JG, Sehmi KS, Hykin PG, Hamilton AM. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999;106:663-668.
25. Stephen J, Kim MD, Robert Equi MD, Neil M, Bressler MD. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007;114:881-889.